Literature DB >> 324918

Purification and characterization of group A streptococcal pyrogenic exotoxin type C.

P M Schlievert, K M Bettin, D W Watson.   

Abstract

Group A streptococcal pyrogenic exotoxin (SPE) type C was partially purified by differential solubility in ethanol and acetate-buffered saline. Toxin prepared in this way consisted of protein and hyaluronic acid. After removal of hyaluronic acid, the toxin remained pyrogenic, enhanced susceptibility of rabbits to letahl endotoxin shock, was stable when treated with acid, base, or pepsin, but was inactivated by heat. Toxin further purified by thin-layer isoelectric focusing was pyrogenic and enhanced the susceptibility of rabbits to lethal endotoxin shock. Purified type C toxin appeared homogeneous when tested by Ouchterlony immunodiffusion and migrated as a single protein band in isoelectric focusing polyacrylamide gels (isoelectric point, 6.7) and sodium dodecyl sulfate-polyacrylamide gels (molecular weight, 13,200). The purified toxin was antigenically distinct from A and B SPE, and antisera raised against the purified toxin neutralized pyrogenic activity. The amino acid composition was determined.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324918      PMCID: PMC421008          DOI: 10.1128/iai.16.2.673-679.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  THE PYROGENIC EFFECT OF SCARLET FEVER TOXIN. I. NEUTRALIZATION WITH ANTITOXIN; THE NATURE OF TOLERANCE.

Authors:  V SCHUH
Journal:  Folia Microbiol (Praha)       Date:  1965-05       Impact factor: 2.099

2.  Studies on adenosine triphosphate transphosphorylases. I. Amino acid composition of adenosine triphosphate-adenosine 5'-phosphate transphosphorylase (myokinase).

Authors:  T A MAHOWALD; E A NOLTMANN; S A KUBY
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Enhanced immune response after immunosuppression by Streptococcal pyrogenic exotoxin.

Authors:  E E Hanna; D W Watson
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

5.  Host-parasite relationships among group A streptococci. IV. Suppression of antibody response by streptococcal pyrogenic exotoxin.

Authors:  E E Hanna; D W Watson
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

6.  Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin.

Authors:  C M Cunningham; E L Barsumian; D W Watson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  HOST-PARASITE RELATIONSHIPS AMONG GROUP A STREPTOCOCCI. 3. DEPRESSION OF RETICULOENDOTHELIAL FUNCTION BY STREPTOCOCCAL PYROGENIC EXOTOXINS.

Authors:  E E HANNA; D W WATSON
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

8.  The pyrogenic effect of scarlet fever toxin. IV. Pyrogenicity of strain C 203 U filtrate: comparison with some basic characteristics of the known types of scarlet fever toxin.

Authors:  V Schuh; V Hríbalová; E Atkins
Journal:  Yale J Biol Med       Date:  1970-08

9.  A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock.

Authors:  Y B Kim; D W Watson
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

10.  Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.

Authors:  D W WATSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

View more
  45 in total

1.  Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2.

Authors:  T N Turner; C L Smith; G A Bohach
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

2.  Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.

Authors:  M A Tomai; P M Schlievert; M Kotb
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

3.  Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin.

Authors:  P M Schlievert; K M Bettin; D W Watson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.

Authors:  Y Kamezawa; T Nakahara; S Nakano; Y Abe; J Nozaki-Renard; T Isono
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

5.  Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production.

Authors:  L P Johnson; M A Tomai; P M Schlievert
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

6.  Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness.

Authors:  P K Lee; P M Schlievert
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

7.  Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies.

Authors:  G A Bohach; C J Hovde; J P Handley; P M Schlievert
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

8.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin.

Authors:  P M Schlievert; D J Schoettle; D W Watson
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved.

Authors:  C M Cunningham; D W Watson
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.